您的购物车当前为空
KCC-07 是一种甲基-CpG 结合域蛋白 2 (MBD2) 的选择性、强效和脑渗透抑制剂,具有抗癌活性。它阻止 MBD2 与甲基化 DNA 结合并激活脑特异性血管生成抑制剂 1,诱导抗增殖 BAI1/p53/p21 信号传导。


为众多的药物研发团队赋能,
让新药发现更简单!
KCC-07 是一种甲基-CpG 结合域蛋白 2 (MBD2) 的选择性、强效和脑渗透抑制剂,具有抗癌活性。它阻止 MBD2 与甲基化 DNA 结合并激活脑特异性血管生成抑制剂 1,诱导抗增殖 BAI1/p53/p21 信号传导。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 278 | In Stock | |
| 2 mg | ¥ 393 | In Stock | |
| 5 mg | ¥ 659 | In Stock | |
| 10 mg | ¥ 987 | In Stock | |
| 25 mg | ¥ 1,830 | In Stock | |
| 50 mg | ¥ 2,730 | In Stock | |
| 100 mg | ¥ 3,990 | In Stock | |
| 500 mg | ¥ 8,490 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 623 | In Stock |
KCC-07 相关产品
| 产品描述 | KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. |
| 体外活性 | 体外实验中,KCC-07处理对髓母细胞瘤(MB)细胞的生长明显抑制,这与抗增殖BAI1/p53/p21信号通路的激活一致。 |
| 细胞实验 | KCC-07?treatment?Medulloblastomas (MB) cells, Concentration with?10 μM and?Incubation Time with?72 hours |
| 分子量 | 269.32 |
| 分子式 | C14H11N3OS |
| CAS No. | 315702-75-1 |
| Smiles | OC1=CC=CC(NC2=NC(=CS2)C2=NC=CC=C2)=C1 |
| 密度 | 1.380 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 22.5 mg/mL (83.54 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.43 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容